The U.S. women’s health and beauty supplements market size was estimated at USD 18.35 billion in 2023 and is expected to grow a CAGR of 4.56% from 2024 to 2030. The rising awareness about health and the growing preference for preventative healthcare are significantly driving the gl... Read More »
April 2024The global diabetic neuropathy treatment market size was estimated at USD 4.34 billion in 2023 and is projected to grow at a CAGR of 7.72% from 2024 to 2030. The market is growing due increasing prevalence of diabetes, advancements in therapeutic & diagnostic techniques, and rising a... Read More »
March 2024The Europe antibiotics market size was estimated at USD 10.9 billion in 2023 and is projected to grow at a CAGR of 3.28% from 2024 to 2030. The rising incidence of infectious diseases is a primary factor propelling the market growth. For instance, according to the European Centre for Dis... Read More »
March 2024The global vaccine contract manufacturing market size was estimated at USD 2.14 billion in 2023 and is projected to grow at a CAGR of 7.8% from 2024 to 2030. Increased demand for vaccines trend of contact manufacturing are key growth contributors to this market. Apart from the safety and... Read More »
March 2024The global anti-obesity medication market size was estimated at USD 6.62 billion in 2023 and is projected to grow at a CAGR of 31.66% from 2024 to 2030. Global obesity is on the rise, creating a demand for effective solutions. Increasing awareness of the health consequences associat... Read More »
March 2024The India active pharmaceutical ingredients market size was estimated at USD 18.29 billion in 2023 and is expected to grow at a CAGR of 7.7% from 2024 to 2030. The market has experienced substantial growth due to the rising burden of chronic diseases, increasing geriatric population, and... Read More »
March 2024The North America active pharmaceutical ingredients market size was estimated at USD 90.88 billion in 2023 and is expected to grow at a CAGR of 4.7% from 2024 to 2030. Increasing prevalence of infectious diseases and hospital-acquired infections coupled with growing prevalence of lifesty... Read More »
March 2024The global clinical nutrition for diabetes care market size was estimated at USD 2.15 billion in 2023 and is expected to register a CAGR of 4.78% from 2024 to 2030. The increasing demand for specialized food products by individuals with diabetes or those at risk of developing the condition is a critical factor for t... Read More »
March 2024The global prediabetes market size was estimated at USD 201.62 million in 2023 and is projected to grow at a CAGR of 7.21% from 2024 to 2030. The increasing incidence of conditions leading to insulin resistance and impaired glucose metabolism, stemming from mutations in specific genes, s... Read More »
March 2024The global urology supplements market size was estimated at USD 1.77 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 8.14% from 2024 to 2030. The market has observed significant growth in recent years owing to increasing awareness, prevalence of kidney ... Read More »
March 2024The global clinical nutrition for cancer care market size was estimated at USD 5.63 billion in 2023 and is expected to grow a compound annual growth rate (CAGR) of 5.04% from 2024 to 2030. The increasing prevalence of cancer and rising awareness about the benefits of medical foods for fa... Read More »
March 2024The France pharmaceuticals market size was estimated at USD 78.78 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 5.16% from 2024 to 2030. France is considered as one of the largest pharmaceutical markets owing to high R&D activities, and transparen... Read More »
February 2024The Africa pharmaceutical market size was estimated at USD 26.85 billion in 2023 and is expected to expand at a compound annual growth rate (CAGR) of 3.4% from 2024 to 2030. This growth is attributed to rising health-consciousness, increasing demand for pharmaceuticals due to chronic dis... Read More »
February 2024The U.S. pharmaceutical market size was estimated at USD 574.37 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 5.48% from 2024 to 2030. This growth can be attributed to rising chronic disease prevalence, escalating geriatric population, increasing... Read More »
February 2024The global pharmaceutical cartridges market size was valued at USD 1.41 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 8.07% from 2024 to 2030. The market is driven by numerous factors such as growing demand for drug delivery devices, rising prevalence... Read More »
February 2024The global sexual health supplements market size was valued at USD 3.52 billion in 2023 and is projected to witness a compound annual growth rate (CAGR) of 10.56% from 2024 to 2030. The growth of the market can be attributed to factors such as growing awareness regarding sexual health is... Read More »
February 2024The Europe cannabidiol market size was estimated at USD 347.7 million in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 25.8% from 2024 to 2030. The market for CBD is predicted to expand in line with the growing acceptance and legalization of products. To cater c... Read More »
February 2024The India in vitro diagnostics market size was valued at USD 394.76 million in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 4.6% from 2024 to 2030. Rising infectious disease testing, chronic disease burden, and a robust lab network drive India's booming in vit... Read More »
February 2024The U.S. point-of-care molecular diagnostics market size was estimated at USD 3.35 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 1.7% from 2024 to 2030. The growth of the market is driven by rise in end-user awareness, along with the increased effici... Read More »
February 2024The global Guillain-Barre Syndrome (GBS) market size was valued at USD 610.5 million in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 4.77% from 2023 to 2030. Rising incidence of Guillain-Barre syndrome (GBS), specifically in regions with high rate of infectio... Read More »
February 2024